CYP8B1 and inflammatory bowel disease: Exogenous CA supplementation or overexpression of CYP8B1 can aggravate the IBD phenotype and damage the intestinal barrier and its repair function in mice, while interference with CYP8B1 expression can promote the relief of intestinal inflammation and restore the ability of intestinal epithelial regeneration [63].